© All rights reserved to Barnea Jaffa Lande Law offices

Efrat Cohen

Electra City Tower
58 Harakevet St.
Tel Aviv
6777016

Efrat Cohen

Efrat Cohen is a Senior Partner in the Regulation Department at our firm.

 

Efrat has extensive experience in regulatory matters across a variety of industries, with a particular focus on the financial, pharmaceutical, and healthcare sectors. Efrat represents shareholders, large companies, and business organizations in complex regulatory proceedings and provides ongoing counsel to management teams and boards of directors on strategic issues and crisis management.

 

In her practice, Efrat provides advice on regulatory and business issues, including assisting with structural changes, the opening of markets to competition, offering legal opinions and formulating positions on emerging regulations, implementing new regulations within organizations, advising on policy development, and drafting internal procedures. She also supports transactions and assists with the obtaining of regulatory approvals, represents clients before public and governmental committees, participates in Knesset committee discussions, and represents clients in hearings, enforcement actions, financial penalties, and administrative petitions.

 

Prior to joining the firm, Efrat served as the Head of the Regulatory and Public Policy Division at the Legal Division of Bank Leumi, alongside holding other senior positions at the bank. Before that, she served as the CEO of “Pharma Israel” (the Association of Multinational Pharmaceutical Companies) and headed the Regulatory Department at a leading and well-known law firm in Israel.

Education:


LL.B., The Hebrew University of Jerusalem, 2002

MBA, The Hebrew University of Jerusalem, 2004

LL.M. in Commercial Law, Tel Aviv University in collaboration with UC Berkeley, 2007

Admission:


The Israeli Bar Association, 2004

Insights & News - Efrat Cohen:


April 7, 2025

Drug registration reform in Israel: processes are being streamlined and timeframes shortened to increase supply and lower prices

The Ministry of Health published a new outline recently, which is designed to shorten the registration timeframes for new drugs. The outline is based on higher cooperation between the Ministry of Health and leading drug registration authorities around the world, while relying on approvals issued in other countries.
March 13, 2025

The Bank of Israel released a preliminary Digital Shekel design for public comment – a real opportunity for competition and innovation?

Last week, the Bank of Israel published a preliminary design of the central bank’s Digital Shekel system. In a detailed document, holding more than 100 pages, the Bank of Israel presents guiding principles and a work plan for further advancing this ambitious project.

See all news updates from Efrat Cohen >